Work

The FDA Declares Levonorgestrel a Nonabortifacient—A 50-Year Saga Takes a Decisive Turn

Year: 2023

Type: article

Abstract: This Viewpoint discusses recent judicial developments and the newly-enunciated FDA position that levonorgestrel is a nonabortifacient.

Source: JAMA Health Forum

DOI: 10.1001/jamahealthforum.2023.2257

Authors: Eli Y. Adashi, I. Glenn Cohen, Allen J. Wilcox

Institutions: Brown University, Harvard University, National Institute of Environmental Health Sciences

Language: English

Topic: Reproductive Health and Contraception

Subfield: Public Health, Environmental and Occupational Health

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: gold

Estimated APC paid: $5,000

OpenAlex ID: W4385564330

FWCI: 1.275

Cites: 4

Cited by: 5

Related to: 10